SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius ($CELH) is trending as investors anticipate upcoming earnings, with some expecting a strong report due to the Alani Nu acquisition and increased distribution with Pepsi. Community members are actively discussing potential price targets and whether the stock will break out, while also noting pre-earnings manipulation. Bullish sentiment seems high, with many believing $CELH is poised for continued growth in the energy drink market.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending following Q3 earnings and a new $400M AI partnership with Perplexity. Community discussions revolve around the potential for a short squeeze and the long-term implications of AI integration for Snap's growth and profitability, with some expressing skepticism about the company's ability to sustain its gains.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo's stock is trending amid discussions about its future growth potential after a significant drop from previous highs. Community members are debating whether the company's AI integration and expansion into new areas like chess will offset concerns about competition from free AI translation tools. Bulls are pointing to the company's solid earnings and user growth, while bears are highlighting valuation concerns and potential disruption from AI.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health's stock is trending amidst mixed sentiment, with some traders citing positive earnings reports and potential ACA extensions as catalysts for a surge, while others express concern about revenue misses and the impact of subsidy changes; the community is actively debating its near-term trajectory and long-term growth potential within the evolving healthcare landscape, with many focused on potential breakout points.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beauty is trending due to a recent sales forecast that disappointed investors, leading to a stock drop and a Piper Sandler downgrade; however, the retail sector remains optimistic. Community discussions revolve around the company's growth potential, tariff impacts, and whether the sell-off is an overreaction. Some traders are eyeing potential bounce plays, while others express concerns about profitability and consumer spending.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root Inc. is trending amidst mixed sentiment after its recent earnings report, with the community debating whether growth is truly accelerating as guided. Bulls point to undervaluation compared to peers like LMND, while bears cite concerns about profitability and sustainability. Discussion also revolves around potential short squeezes and upcoming catalysts.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna's stock is trending amid speculation surrounding a potential acquisition or "deal of significant scope" with a major drugmaker, fueled by a report from STAT News. The community is actively discussing potential buyout prices and speculating on which company might acquire Moderna, with some citing the company's mRNA platform and oncology pipeline as key assets. Despite the excitement, concerns remain regarding upcoming earnings and the company's future growth prospects beyond COVID-19 vaccines.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending amid speculation around a potential SoftBank takeover, driving community discussion on the importance of Marvell's IP and its photonics business. Some investors believe the company is undervalued with significant growth potential, while others are more cautious, citing past underperformance. The overall sentiment suggests renewed interest in MRVL, potentially fueled by AI-related growth prospects within the semiconductor sector.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as investors discuss the company's revenue growth, potential profitability, and upcoming earnings report. Community members are also highlighting institutional ownership and potential for a buyout, with some speculating on the impact of its innovative drug delivery technologies. Anticipation surrounds upcoming presentations and potential positive catalysts for the stock.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending amid positive analyst updates and increasing optimism around its AI-driven advertising platform, Axon. Community members are discussing the potential for revenue growth in e-commerce and the company's ability to maintain high margins. Despite a recent pullback, many anticipate a rebound leading up to earnings, with some speculating about a potential price target increase.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Goldman Sachs’ updated price target on the stock implies a 17% potential upside from Wednesday’s closing price of $617.05</li><li>The company’s Q3 revenue and EPS beat street estimates</li><li>Applovin is among the top trending stocks on Stocktwits</li></ul>&nbsp;Shares of Applovin Corp. (APP) were up nearly 7% in premarket trade on Thursday after Goldman Sachs raised its price target on the stock following the company’s better-than-expected third-quarter results.Goldman Sachs raised the price target to $720 from $630, while maintaining a ‘Neutral’ rating, implying a 17% upside from Wednesday’s closing price of $617.05. The firm cited strong third-quarter results, supported by robust advertising revenue growth through the company’s AXON 2.0 platform.AXON is AppLovin’s proprietary AI-powered system that evaluates every advertisement impression in real time.The firm highlighted management’s confidence in the early rollout of its new self-serve eCommerce advertising portal, which launched late in the third quarter (Q3), noting its potential to extend AXON 2.0’s reach into non-gaming ad demand through 2026 and beyond.Goldman also emphasized the company’s strong profitability, projecting over 85% incremental adjusted&nbsp;Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) margins supported by a current gross margin of 78.6% and $3.43 billion in EBITDA.<h2 class="st-heading-2">Upbeat Q3</h2>Applovin’s Q3 revenue came in at $1.41 billion, up 68% year over year and above estimates of $1.34 billion, according to Stocktwits data. Net income nearly doubled to $836 million, while its earnings per share (EPS) of $2.45 exceeded estimates of $2.38.For the fourth quarter, the company expects revenue between $1.57 billion and $1.6 billion, adjusted EBITDA of $1.29 billion to $1.32 billion, and an adjusted EBITDA margin of 82% to 83%.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits flipped to ‘bullish’ from ‘bearish’ territory a session earlier, accompanied by ‘high’ message volumes. At the time of writing, <a href="https://stocktwits.com/symbol/APP">Applovin</a> was among the top trending tickers on Stocktwits.<figure class="image"><img style="aspect-ratio:925/87;" src="https://news.stocktwits-cdn.com/APP_png_e9a620cdbf.webp" alt="APP.png" width="925" height="87"><figcaption>APP's Sentiment Meter and Message Volumes at 06:45 a.m. ET on November 6, 2025 | Source: Stocktwits</figcaption></figure>One user expects the stock to rise to $725 to $730 by Friday.<stembedurl>https://stocktwits.com/RealBobbyAxelrod/message/635124940</stembedurl>The stock is currently 20% below its recently hit all-time high of $745. APP shares have seen strong buying interest in 2025 so far, gaining nearly 87%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the AppLovin Corporation logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Why Is Applovin Stock Rising Today?

Goldman Sachs increased Applovin’s target price after its better-than-expected Q3 print.

Equity

<ul class="summary-bullets"><li>The Trump administration faced skepticism from conservative justices during early arguments in the crucial tariffs case at the Supreme Court.</li><li>This included questioning whether the International Emergency Economic Powers Act authorized President Donald Trump to impose emergency tariffs.</li><li>Asian markets ended Thursday’s trading session on a positive note, with the Hang Seng index gaining the most at 2.03%.</li></ul>U.S. stocks appear set for a cautious opening on Thursday, as investors take a pause following concerns about AI valuations and the Supreme Court hearing on President Donald Trump’s tariffs case.The Trump administration reportedly&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-tariffs-case-supreme-court/cL2q8jQREG6">faced skepticism</a> from conservative justices during early arguments in the crucial tariffs case at the Supreme Court. Chief Justice John Roberts and Justice Amy Coney Barrett pressed the Trump administration on a range of issues.This included questioning whether the International Emergency Economic Powers Act (IEEPA) authorized President Donald Trump to impose emergency tariffs.<h2 class="st-heading-2">Futures Trade Mixed</h2>While Dow Jones futures edged lower by 0.02% at the time of writing, the S&amp;P 500 futures rose 0.09%, while the tech-heavy Nasdaq 100’s futures gained 0.06%. Futures of the Russell 2000 index edged up by 0.01%.Meanwhile, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY) was up 0.1% at the time of writing. Invesco QQQ Trust (QQQ) gained 0.06% on Thursday morning, and the SPDR<a href="https://stocktwits.com/symbol/DIA"> Dow Jones Industrial Average ETF Trust</a> (DIA) declined 0.02%. Retail sentiment around the S&amp;P 500 ETF on Stocktwits was in the ‘bearish’ territory.<h2 class="st-heading-2">Asian Markets Rise</h2>Asian markets ended Thursday’s trading session on a positive note, with the Hang Seng index gaining the most at 2.03%, followed by the Nikkei 225 at 1.38%, and the Shanghai Composite at 0.96%.The TWSE Capitalization Weighted Stock index gained 0.65%, while the KOSPI rose 0.55%.<h2 class="st-heading-2">Stocks To Watch</h2><ul><li>Tesla Inc. (TSLA): Tesla shares edged up nearly 1% in Thursday’s pre-market trade ahead of the results of a shareholder vote on CEO Elon Musk’s $1 trillion compensation plan.</li><li>AppLovin Corp. (APP): AppLovin shares were up nearly 7% pre-market after the company’s third-quarter (Q3) results beat Wall Street expectations. AppLovin reported earnings per share (EPS) of $2.45 on revenue of $1.41 billion, compared to analyst estimates of an EPS of $2.38 on revenue of $1.34 billion, according to Stocktwits data.</li><li>DoorDash Inc. (DASH): DoorDash shares were down nearly 10% pre-market after the company’s mixed performance in Q3. DoorDash reported an EPS of $0.55 on revenue of $3.45 billion, compared to analyst expectations of an EPS of $0.68 on revenue of $3.35 billion, according to Stocktwits data.</li><li>Snap Inc. (SNAP): Snap shares soared 20% in Thursday’s pre-market session after the company’s Q3 results beat Wall Street expectations. Snap reported a loss of $0.06 per share, compared to an estimated loss of $0.12 per share, while its revenue came in at $1.51 billion, slightly above the expected $1.49 billion. The company also announced a partnership with Perplexity AI to integrate the latter’s search engine in the Snapchat app.</li><li>Indie Semiconductor Inc. (INDI), Moderna Inc. (MRNA), and Airbnb Inc. (ABNB) are among the companies scheduled to report their latest quarterly earnings on Thursday.</li></ul>&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-tariffs-case-supreme-court/cL2q8jQREG6">Tariffs Case In Supreme Court: Trump Administration Reportedly Faces Skepticism From Conservative Justices</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

People walk by the New York Stock Exchange

Dow Futures Trade Flat As Markets Continue To Consolidate: TSLA, APP, DASH, SNAP Among Stocks To Watch

While Dow Jones futures edged lower by 0.02% at the time of writing, the S&P 500 futures rose 0.09%.

Markets Positive on Supreme Court Ruminations, Big Earnings

A ban on tariff policy would likely provide a major market catalyst to the upside.

AppLovin (APP) Beats Q3 Earnings and Revenue Estimates

AppLovin (APP) delivered earnings and revenue surprises of +3.38% and +4.11%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

QXO Gears Up to Report Q3 Earnings: What's in the Cards?

QXO is likely to have witnessed another standout quarter, with earnings and revenues expected to increase more than double year over year.

Willdan Group to Post Q3 Earnings: What's in the Cards?

WLDN gears up for Q3 results, with earnings set to rise even as revenues face a year-over-year decline.

Palantir Gears Up to Report Q3 Earnings: Here's What You Should Know

PLTR is likely to post Q3 2025 results, with earnings and revenue estimates signaling sharp double-digit growth.

Broadridge Set to Report Q1 Earnings: What's in the Cards?

BR is likely to gear up to post Q1 fiscal 2026 results, with estimates pointing to strong earnings and revenue growth.

MEG Gears Up to Report Q3 Earnings: Here's What You Should Know

Montrose Environmental expects solid Q3 revenue gains across all segments, though earnings are likely to have slipped year over year.

3 Reasons Why AppLovin (APP) Is a Great Growth Stock

AppLovin (APP) possesses solid growth attributes, which could help it handily outperform the market.

$APP Q3 &#39;25 Earnings Results &amp; Recap 
 
AppLovin reported strong Q3 results with revenue of $1.41 billion (vs. $1.34 billion estimate) and adjusted EBITDA of $1.16 billion. For Q4 2025, the company expects revenue between $1.57 billion and $1.6 billion, and adjusted EBITDA between $1.29 billion and $1.32 billion.

Stocktwits

 Q3 '25 Earnings Results & Recap 
 
AppLovin reported strong Q3 results with revenue of $1.41 billion (vs. $1.34 billion estimate) and adjusted EBITDA of $1.16 billion. For Q4 2025, the company expects revenue between $1.57 billion and $1.6 billion, and adjusted EBITDA between $1.29 billion and $1.32 billion.

This account has been verified as an official STOCKTWITS representative.

APP
Applovin Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Earnings Recap

Latest APP News

APPApplovin Corp